Similar Posts
Gold at record, stocks mixed as investors weigh Trump's latest tariff threat
Gold at record, stocks mixed as investors weigh Trump's latest tariff threat Source link
Titagarh Rail Systems, Senco Gold among 8 smallcap stock ideas for 2025: Antique Stock Broking – Top Picks
The Nifty 50 index wrapped up 2024 with over 8% annual returns, and is projected to hit 26,500 mark by March 2026 – reflecting 10% potential upside from current levels, driven by evolving consumption dynamics, the rise of mid-cap and small-cap stocks and a strong capital expenditure revival, according to Antique Stock Broking. Sectors such…
Clean Sweep Recap, 3 New Plays to End the Week
Thursday’s Performance: We’re wrapping up this week with another pleasant report, after we managed another sweep of our daily board on Thursday. Our premarket report for the day contained a slate of three potential plays, and all three ranges experienced significant intraday upswings. With just one single idea on Monday being the only call we missed on…
Jan 17, 2025 Higher Oil Prices Ahead? | Stocks Approach Records | Gold Gains Despite Dollar Strength
Watch this video on YouTube!youtu.be/eHNQfVI19ng 4-Hour Chart of S&P500 ExaminedStocks Approach Records AgainHigh-Yield Junk Bonds Exhibit Bullish Divergence to Stocks – This is good for stocksGold Moves Higher Despite Strong DollarEnergy Companies Show Strength. This could mean higher prices at the gas pump Stocks Covered In Members Only Video:Market Breadth, Junk Debt, Crude Oil, Silver,…
ASX – ASX Limited
Todays news http://www.news.com.au/heraldsun/story/0,21985,21045214-664,00.html Even the ASX may be targetStephen McMahon with AAP January 12, 2007 12:00am THE New York Stock Exchange — possibly working with Macquarie Bank — is rumoured to be lining up a takeover bid for the ASX. The takeover talk sent the company’s share price up almost 4.5 per cent, or $1.60,…
Zydus Lifesciences to raise Rs 5,000 cr via equity; Q2 profit up 38%
Zydus Lifesciences’ board on Thursday approved a proposal to raise up to Rs 5,000 crore through a share sale, which the pharmaceutical company said will help strengthen its balance sheet by reducing debt and fuel future growth. The fundraising may be executed in one or more tranches through a public or private sale of shares…